Stroke is ideally suited for prevention. 1 It has a high prevalence, burden of illness, and economic cost, and safe and effective prevention measures.
The estimated $30 billion that is being spent for stroke each year in the United States should not come as a surprise given the approximately 3 million stroke survivors and 400 000 to 500 000 new or recurrent stroke cases annually. 2 Stroke remains the third leading cause of death among adults3 and has been targeted for cost containment by managed care health systems and other insurers.
The US Public Health Service in conjunction with the National Health Promotion and Disease Prevention Objectives has set a goal to reduce stroke deaths to 20 per 100 000 by the year 2000.4 This goal could be attained as the estimate of « preventable » strokes could be as high as 80%. 5 In this article, I will review the status of stroke risk factors, prevention approaches to reduce stroke, clinical trial data from primary and secondary stroke prevention studies, and future directions in stroke prevention.
Mots-clés Pascal : Accident cérébrovasculaire, Etats Unis, Amérique du Nord, Amérique, Prévention, Facteur risque, Article synthèse, Homme, Système nerveux pathologie, Système nerveux central pathologie, Encéphale pathologie, Cérébrovasculaire pathologie, Appareil circulatoire pathologie, Vaisseau sanguin pathologie
Mots-clés Pascal anglais : Stroke, United States, North America, America, Prevention, Risk factor, Review, Human, Nervous system diseases, Central nervous system disease, Cerebral disorder, Cerebrovascular disease, Cardiovascular disease, Vascular disease
Notice produite par :
Inist-CNRS - Institut de l'Information Scientifique et Technique
Cote : 95-0321814
Code Inist : 002B17C. Création : 01/03/1996.